Moderna stands to earn $300M for quick vaccine approval, up to $6.6B for extra doses: filing

Moderna’s coronavirus vaccine deal with the U.S., announced last week with a $ 1.525 billion price tag, would be worth far more if all options are exercised—and if the mRNA biotech meets an aggressive timeline for the shot’s arrival. The company stands to gain up to a whopping $ 8.125 billion, according to a Moderna… Read More »

Doctor, hospital groups have created a roadmap for keeping essential surgeries during a COVID-19 surge

The recent resurgence of COVID-19 has many states near or at bed and intensive care unit capacity, and healthcare facilities’ ability to meet the ongoing needs of surgical patients may be stressed by new influxes of coronavirus patients admitted to healthcare facilities. To ensure healthcare organizations, physicians and nurses remain prepared to meet these demands… Read More »